Siemens has agreed to acquire Dotmatics for $5.1 billion to strengthen its position in the life sciences sector, leveraging advanced R&D software and AI capabilities.

Overview of the Deal

The acquisition of Dotmatics by Siemens is designed to enhance Siemens' presence in the life sciences segment of industrial software, complementing its strong foothold in discrete industrials and electrical & electronics sectors. With this acquisition, Siemens aims to leverage its expertise in research and development applications alongside data management to further penetrate the life sciences market.

This strategic acquisition is set at a total transaction size of $5.1 billion, which represents a 39x multiple of the expected EBITDA for the fiscal year ending September 2025. The financing for this deal is anticipated through share sales, and it is expected to be immediately accretive to Siemens' free cash flow even before the inclusion of projected revenue synergies totaling $100 million per year.

Information on Dotmatics

Founded in 2005 and headquartered in Boston, USA, Dotmatics is a prominent R&D software company specializing in web-based scientific solutions. The company focuses on enhancing collaboration, automation, and analysis in research laborator

View Source

Similar Deals

GE HealthCare Intelerad

2026

Merger Medical Imaging Systems United States of America
Novartis AG Avidity Biosciences, Inc.

2026

Merger Proprietary & Advanced Pharmaceuticals United States of America
Laborie Medical Technologies Corp. JADA System

2026

Merger Medical Devices & Implants United States of America
GEON Performance Solutions Foster Corporation

2025

Merger Medical Devices & Implants United States of America
Matthews International Corporation The Dodge Company, Inc.

2025

Merger Medical Supplies United States of America
CRScube Mednet

2025

Merger Biotechnology & Medical Research (NEC) United States of America

Siemens

invested in

Dotmatics

in 2025

in a Merger deal

Disclosed details

Transaction Size: $5,100M

Revenue: $300M

EBITDA: $120M

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert